Parkin-related disease clinically diagnosed as a pallido-pyramidal syndrome

Movement Disorders

Volumn 24, Issue 1, 2009, Pages 138-140

  Wickremaratchi, Mindhu M ^a   Majounie, Elisa ^a   Morris, Huw R ^a   Williams, Nigel M ^a   Lewis, Helen ^b   Gill, Steven S ^b   Khan, Sadaquate ^b   Heywood, Peter ^b   Hardy, John ^c,d   Wiles, Charles M ^a   Singleton, Andrew B ^c   Quinn, Niall P ^e  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PARKIN;

ADOLESCENT; ADULT; ARTICLE; BLADDER DISEASE; BRADYKINESIA; BRAIN ATROPHY; BRAIN DEGENERATION; BRAIN DEPTH STIMULATION; CASE REPORT; CHILD; CONFUSION; CONSTIPATION; DRUG TOLERABILITY; DYSKINESIA; DYSPHAGIA; DYSTONIA; GAIT DISORDER; GENE MUTATION; GLOBUS PALLIDUS; HALLUCINATION; HUMAN; HYPERREFLEXIA; MALE; MEMORY DISORDER; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; NEUROSURGERY; ONSET AGE; PALLIDO PYRAMIDAL SYNDROME; PARKINSONISM; PRIORITY JOURNAL; QUADRIPLEGIA; SLURRED SPEECH; TREMOR;

AGE OF ONSET; ANTIPARKINSON AGENTS; CHILD; CHILD, PRESCHOOL; CHOLINERGIC ANTAGONISTS; COMBINED MODALITY THERAPY; DEEP BRAIN STIMULATION; DYSARTHRIA; EXONS; FEMALE; GAIT DISORDERS, NEUROLOGIC; GLOBUS PALLIDUS; HUMANS; MALE; PARKINSONIAN DISORDERS; PYRAMIDAL TRACTS; SYNDROME; UBIQUITIN-PROTEIN LIGASES;

EID: 61449240281     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22181     Document Type: Article

References (22)

1. Hardy J, Cai H, Cookson MR, Gwinn-Hardy K, Singleton A. Genetics of Parkinson's disease and Parkinsonism. Ann Neurol 2006;60:389-398.
2. Gibb WR, Lees AJ. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol 1989;15:27-44.
3. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
4. Gwinn-Hardy K, Chen JY, Liu HC, et al. Spinocerebellar ataxia type 2 with Parkinsonism in ethnic Chinese. Neurology 2000;55: 800-805.
5. Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-Parkinsonism. Brain 2005;128(Part 6):1247-1258.
6. Plaha P, Ben-Shlomo Y, Patel NK, Gill SS. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral Parkinsonism. Brain 2006;129 (Part 7):1732-1747.
7. Simon-Sanchez JSS, Matarin M, Fung H-C, et al. Genome-wide SNP assay reveals mutations underlying Parkinson's disease. Hum Mutat 2007.
8. Jankovic J. Searching for a relationship between manganese and welding and Parkinson's disease. Neurology 2005;64:2021-2028.
9. Hayashi S, Wakabayashi K, Ishikawa A, et al. An autopsy case of autosomal-recessive juvenile Parkinsonism with a homozygous exon 4 deletion in the parkin gene. Mov Disord 2000;15:884-888.
10. Farrer M, Chan P, Chen R, et al. Lewy bodies and Parkinsonism in families with parkin mutations. Ann Neurol 2001;50:293-300.
11. van de Warrenburg BP, Lammens M, Lucking CB, et al. Clinical and pathologic abnormalities in a family with Parkinsonism and parkin gene mutations. Neurology 2001;56:555-557.
12. Sasaki S, Shirata A, Yamane K, Iwata M. Parkin-positive autosomal recessive juvenile Parkinsonism with α-synuclein-positive inclusions. Neurology 2004;63:678-682.
13. Pramstaller PP, Schlossmacher MG, Jacques TS, et al. Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers. Ann Neurol 2005;58:411-422.
14. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile Parkinsonism. Nature 1998;392:605-608.
15. Abbas N, Lucking CB, Ricard S, et al. A wide variety of mutations in the Parkin gene are responsible for autosomal recessive Parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Hum Mol Genet 1999;8:567-574.
16. Lucking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med 2000;342:1560-1567.
17. Lohmann E, Periquet M, Bonifati V, et al. How much phenotypic variation can be attributed to parkin genotype? Ann Neurol 2003;54:176-185.
18. Periquet M, Latouche M, Lohmann E, et al. Parkin mutations are frequent in patients with isolated early-onset Parkinsonism. Brain 2003;126 (Part 6):1271-1278.
19. Khan NL, Graham E, Critchley P, et al. Parkin disease: a phenotypic study of a large case series. Brain 2003;126 (Part 6):1279-1292.
20. Poorkaj P, Nutt JG, James D, et al. Parkin mutation analysis in clinic patients with early-onset Parkinson [corrected] disease. Am J Med Genet A 2004;129:44-50.
21. Lesage S, Magali P, Lohmann E, et al. Deletion of the parkin and PACRG gene promoter in early-onset Parkinsonism. Hum Mutat 2007;28:27-32.
22. Hedrich K, Eskelson C, Wilmot B, et al. Distribution, type, and origin of parkin mutations: review and case studies. Mov Disord 2004;19:1146-1157.